4//SEC Filing
Golembiewski Michael Joseph 4
Accession 0001104659-23-122841
CIK 0001017491other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:16 PM ET
Size
5.6 KB
Accession
0001104659-23-122841
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-11-30$1.21/sh+83,000$100,223→ 86,450 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $1.07 per share to $1.27 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.
- [F2]Effective on November 28, 2023, the Issuer conducted a reverse stock split at a ratio of 1-for-30 (the "Reverse Split"). The number of shares reported herein reflects the number of shares after the Reverse Split.
Documents
Issuer
SEELOS THERAPEUTICS, INC.
CIK 0001017491
Entity typeother
Related Parties
1- filerCIK 0001639479
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:16 PM ET
- Size
- 5.6 KB